Disease-modifying treatment explained

A disease-modifying treatment, disease-modifying drug, or disease-modifying therapy is a treatment that delays, slows or reverses the progression of a disease by targeting its underlying cause.[1] They are distinguished from symptomatic treatments that treat the symptoms of a disease but do not address its underlying cause.[2]

Examples

Notes and References

  1. McFarthing . Kevin . Rafaloff . Gary . Baptista . Marco . Mursaleen . Leah . Fuest . Rosie . Wyse . Richard K. . Stott . Simon R.W. . 2022-05-24 . Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update . Journal of Parkinson's Disease . 12 . 4 . 1073–1082 . 10.3233/JPD-229002 . 9198738 . 35527571.
  2. Web site: Symptomatic Versus Disease-Modifying Therapies for Movement Disorders - Parkinson's and Movement Disorder Foundation . 2022-09-11 . pmdf.org.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Disease-modifying treatment".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.